# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Sotera Health shares are trading higher by 5.5% during Thursday's session. The company late Wednesday announced a secondary...
It is expected that, as a result of the Offering, the Company's sponsors (affiliates of Warburg Pincus and GTCR) will cease...
Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $14 to...
RBC Capital analyst Sean Dodge reiterates Sotera Health (NASDAQ:SHC) with a Outperform and maintains $17 price target.
2024 Outlook Today, Sotera Health is reaffirming the 2024 outlook previously provided. As a reminder, the outlook is: Net r...